Brainstorm Cell Therapeutics | BCLI - Pre Tax Profit


Brainstorm Cell Therapeutics reported $-2.11M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Biogen USD 557.3M 186.7M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
Grifols EUR 257.85M 190.87M Dec/2024
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Mesoblast USD -54.09M 6.37M Jun/2025